The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.
Influence of GluN2 subunit identity on NMDA receptor function
Open accessAbstract
N-methyl-d-aspartate receptors (NMDARs) are ligand-gated ion channels ('ionotropic' receptors) activated by the major excitatory neurotransmitter, l-glutamate. While the term 'the NMDAR' is often used it obscures the fact that this class of receptor contains within it members whose properties are as different as they are similar. This heterogeneity was evident from early electrophysiological, pharmacological and biochemical assessments of the functional properties of NMDARs and while the molecular basis of this heterogeneity has taken many years to elucidate, it indicated from the outset that the diversity of NMDAR phenotypes could allow this receptor family to subserve a variety of functions in the mammalian central nervous system. In this review we highlight some recent studies that have identified structural elements within GluN2 subunits that contribute to the heterogeneous biophysical properties of NMDARs, consider why some recently described novel pharmacological tools may permit better identification of native NMDAR subtypes, examine the evidence that NMDAR subtypes differentially contribute to the induction of long-term potentiation and long-term depression and discuss how through the use of chimeric proteins additional insights have been obtained that account for NMDAR subtype-dependency of physiological and pathophysiological signalling. This article is part of the Special Issue entitled 'Glutamate Receptor-Dependent Synaptic Plasticity'.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are permeant to Ca 2+ , which mediates many of the consequences of NMDAR activity, including synaptic modification, learning and memory, activity-dependent development, and neuroprotective/homeostatic signaling [6][7][8] .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Collingridge, G. L., Kehl, S. J., & McLennan, H. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014478 · Cited by 2,413
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
Wong, E. H. F., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N., & Iversen, L. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7104 · Cited by 1,820
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 4×
“The specific sub-cellular localisation of GluN2A and GluN2Bcontaining NMDARs within the adult forebrain has been of considerable interest given the differing roles of synaptic and extrasynaptic NMDARs in signalling to neuronal survival and death (reviewed in Hardingham and Bading, 2010).”
BackgroundInfluentialSelf-citationPDZ domain proteins of synapses
Kim, E., & Sheng, M. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1517 · Cited by 1,630
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,385
Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
Sheng, M., Cummings, J., Roldan, L. A., Jan, Y. N., & Jan, L. Y. (1994) · Nature · doi:10.1038/368144a0 · Cited by 1,377
Ciabarra, A., Sullivan, J., Gahn, L. G., Pecht, G., Heinemann, S., & Sevarino, K. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06498.1995 · Cited by 1,260
Flagged first, then by citations
1 of the 161 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 263
Lv, J.-M., Guo, X., Chen, B., Lei, Q., Pan, Y., & Yang, Q. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0257-8 · Cited by 22
Importance of the GluN2B carboxy-terminal domain for enhancement of social memories
Jacobs, S., Wei, W., Wang, D., & Tsien, J. Z. (2015) · Learning & Memory · doi:10.1101/lm.038521.115 · Cited by 22
Zhu, J., Xu, S., Li, S., Yang, X., Yu, X., & Zhang, X. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00976 · Cited by 21
Ma, T., Cheng, Q., Chen, C., Luo, Z., & Feng, D. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00298-w · Cited by 22
Postsynaptic Proteins at Excitatory Synapses in the Brain—Relationship with Depressive Disorders
Samojedny, S., Czechowska, E., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911423 · Cited by 22
NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease
Haddow, K., Kind, P. C., & Hardingham, G. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911392 · Cited by 22
Self-citationKamal, T., Green, T. N., Morel‐Kopp, M., Wård, C., McGregor, A. L., McGlashan, S. R., Bohlander, S. K., Browett, P., Teague, L. R., During, M. J., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.004 · Cited by 21
Thacker, J. S., Xu, Y., Tang, C., Tupling, A. R., Staines, R. W., & Mielke, J. G. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.051 · Cited by 21
Moldavski, A., Behr, J., Bading, H., & Bengtson, C. P. (2019) · The Journal of Physiology · doi:10.1113/jp278362 · Cited by 18
Marrone, L., Marchi, P. M., Webster, C. P., Marroccella, R., Coldicott, I., Reynolds, S., Alves-Cruzeiro, J., Yang, Z.-L., Higginbottom, A., Khundadze, M., et al. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac063 · Cited by 16
Self-citationÇalışkan, G., Raza, S. A., Demiray, Y. E., Kul, E., Sandhu, K. V., & Stork, O. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1698826 · Cited by 17
NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus
Punnakkal, P., & Dominic, D. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8477-y · Cited by 18
Longhena, F., Zaltieri, M., Grigoletto, J., Faustini, G., Via, L. L., Ghidoni, R., Benussi, L., Missale, C., Spano, P., & Bellucci, A. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242164 · Cited by 19
Morris, P. G., Mishina, M., & Jones, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00354 · Cited by 18
Perszyk, R. E., Zheng, Z., Banke, T. G., Zhang, J., Xie, L., McDaniel, M. J., Katzman, B. M., Pelly, S. C., Yuan, H., Liotta, D. C., et al. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000218 · Cited by 17
Bajaj, G., Hau, A. M., Hsu, P., Gafken, P. R., Schimerlik, M. I., & Ishmael, J. E. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.111 · Cited by 17
Lüken, J., Goerges, G., Ritter, N., Disse, P., Schreiber, J. A., Schmidt, J., Frehland, B., Schepmann, D., Seebohm, G., & Wünsch, B. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01161 · Cited by 16
Marty, F. H., Bettamin, L., Thouard, A., Bourgade, K., Allart, S., Larrieu, G., Malnou, C. E., Gonzalez‐Dunia, D., & Suberbielle, E. (2021) · iScience · doi:10.1016/j.isci.2021.103621 · Cited by 16
Nouhi, M., Zhang, X., Yao, N., & Chergui, K. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12784 · Cited by 16
The human NMDA receptor GluN2AN615K variant influences channel blocker potency
Marwick, K. F. M., Skehel, P., Hardingham, G. E., & Wyllie, D. J. A. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.495 · Cited by 16
Self-citationZelek-Molik, A., Bobula, B., Gądek-Michalska, A., Chorążka, K., Bielawski, A., Kuśmierczyk, J., Siwiec, M., Wilczkowski, M., Hess, G., & Nalepa, I. (2021) · Biomolecules · doi:10.3390/biom11020294 · Cited by 16
Schreiber, J. A., Müller, S. L., Westphälinger, S., Schepmann, D., Strutz‐Seebohm, N., Seebohm, G., & Wünsch, B. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.006 · Cited by 15
Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators
Niu, M., Yang, X., Li, Y., Sun, Y., Wang, L., Ha, J., Xie, Y., Gao, Z., Tian, C., Wang, L., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01185-1 · Cited by 16
Christiaans, J. A. M., Klein, P. J., Metaxas, A., Kooijman, E. J. M., Schuit, R. C., Leysen, J. E., Lammertsma, A. A., van Berckel, B. N. M., & Windhorst, A. D. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.04.131 · Cited by 15
Mao, Z., He, S., Mesnard, C., Synowicki, P., Zhang, Y., Chung, L., Wiesman, A. I., Wilson, T. W., & Monaghan, D. T. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146571 · Cited by 14
Raith, H., Schuelert, N., Duveau, V., Roucard, C., Plano, A., Dorner‐Ciossek, C., & Ferger, B. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108072 · Cited by 16
Colitti-Klausnitzer, J., Hagena, H., Dubovyk, V., & Manahan‐Vaughan, D. (2021) · Hippocampus · doi:10.1002/hipo.23338 · Cited by 13
The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action
Vestring, S., Veleanu, M., Perez, M. C., Schuberth, L. E., Bronnec, M., Li, A., Würz, L. M., Erdogdu, F., Stocker, J., Moos, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66774-w · Cited by 13
Protein quality control of N-methyl-D-aspartate receptors
Benske, T. M., Mu, T., & Wang, Y. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.907560 · Cited by 12
N-Methyl-D-Aspartate Receptors in Hematopoietic Cells: What Have We Learned?
Kalev‐Zylinska, M. L., Hearn, J. I., Makhro, A., & Bogdanova, A. Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00577 · Cited by 14
Bates, R. C., Stith, B. J., Stevens, K. E., & Adams, C. E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.004 · Cited by 11
Couturier, C. S., Stecyk, J. A. W., Ellefsen, S., Sandvik, G. K., Milton, S., Prentice, H. M., & Nilsson, G. (2019) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2018.12.010 · Cited by 12
Ding, Y., Wang, L., Huo, Y., Sun, Y., Wang, L., Gao, Z., & Sun, Y. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24574 · Cited by 12
Neupane, C., Sharma, R., Pai, Y. H., Lee, S. Y., Jeon, B. H., Kim, H., Stern, J. E., & Park, J. B. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1742-20.2020 · Cited by 12
Rittase, W. B., Dong, Y., Barksdale, D., Galdzicki, Z., & Bausch, S. B. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.04.002 · Cited by 11
The Good and Bad Sides of NAAG
Khacho, P., Wang, B., & Bergeron, R. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.003 · Cited by 10
Functional assessment of the NMDA receptor variant GluN2AR586K
Marwick, K. F. M., Parker, P. J., Skehel, P., Hardingham, G. E., & Wyllie, D. J. A. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10985.1 · Cited by 10
Self-citationHow is Excitotoxicity Being Modelled in iPSC-Derived Neurons?
Cheng, J. L., Cook, A. L., Talbot, J., & Perry, S. E. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00721-3 · Cited by 10
He, Y., Mu, L., Ametamey, S. M., & Schibli, R. (2019) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3744 · Cited by 10
A new villain in neuronal death
Jones, S. (2020) · Science · doi:10.1126/science.abe2791 · Cited by 10
Morini, R., Ferrara, S., Perrucci, F., Zambetti, S., Pelucchi, S., Marcello, E. E., Gardoni, F., Antonucci, F., Matteoli, M., & Menna, E. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00313 · Cited by 10
Microglial Priming in Bilirubin-Induced Neurotoxicity
Huang, H., Li, S., Zhang, Y., He, C., & Hua, Z. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00643-6 · Cited by 9
Reyes-Guzmán, E. A., Vega, N. A., Reyes-Montaño, E. A., & Recio‐Pinto, E. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0361-4 · Cited by 9
Age and activation determines the anticonvulsant effect of ifenprodil in rats
Mareš, P. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-0987-z · Cited by 9
Early expression of GluN2A-containing NMDA receptors in a model of fragile X syndrome
Banke, T. G., Traynelis, S. F., & Barría, A. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00406.2023 · Cited by 9
Keith, R. E., Wild, G. A., Keith, M. J., Chen, D., Pack, S., & Dumas, T. C. (2024) · Synapse · doi:10.1002/syn.22292 · Cited by 11
Cellot, G., & Ballerini, L. (2025) · Life · doi:10.3390/life15111776 · Cited by 10
Markus, A., Schepmann, D., & Wünsch, B. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200020 · Cited by 7
Deutsch, S. I., & Burket, J. A. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.05.002 · Cited by 7
Song, R., Zhang, J., Perszyk, R. E., Camp, C. R., Tang, W., Kannan, V., Li, J., Xu, Y., Chen, J., Li, Y., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15942 · Cited by 7
Yamagishi, A., Ikekubo, Y., Mishina, M., Ikeda, K., & Ide, S. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.01.008 · Cited by 7
Yasmin, F., Marwick, K. F. M., Hunter, D., Nawaz, S., Marshall, G. F., Booker, S. A., Hardingham, G. E., Kind, P. C., & Wyllie, D. J. A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf124 · Cited by 7
Self-citationNarita, S., Onozawa, Y., Yoshihara, E., Nishizawa, D., Numajiri, M., Ikeda, K., & Iwahashi, K. (2018) · East Asian Archives of Psychiatry · doi:10.12809/eaap181712 · Cited by 7
Vinnakota, C., Schroeder, A., Du, X., Ikeda, K., Ide, S., Mishina, M., Hudson, M. R., Jones, N. C., Sundram, S., & Hill, R. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25257 · Cited by 5
Lee, C., Joo, K., Kim, M., Rhie, D., & Jang, H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23604 · Cited by 7
Effect of NMDA, a Specific Agonist to NMDA Receptor Complex, on Rat Hippocampus
Мотин, В. Г., & Yasnetsov, V. V. (2015) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-015-3053-z · Cited by 7
Inhibition of GluN2A-Containing N-Methyl-d-Aspartate Receptors by 2-Naphthoic Acid
Yu, H., & Popescu, G. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087189 · Cited by 7
Age-dependent effects on social interaction of NMDA GluN2A receptor subtype-selective antagonism
Green, T. L., Burket, J. A., & Deutsch, S. I. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.017 · Cited by 7
Li, Y., Ding, R., Wang, F., Guo, C., Liu, A., Wei, L., Yuan, S., Chen, F., Hou, S., Ma, Z., et al. (2020) · Aging · doi:10.18632/aging.102881 · Cited by 7
A novel NMDA receptor test model based on hiPSC-derived neural cells
Disse, P., Aymanns, I., Ritter, N., Peischard, S., Korn, L., Wiendl, H., Pawlowski, M., Kovac, S., Meuth, S. G., Budde, T., et al. (2023) · Biological Chemistry · doi:10.1515/hsz-2022-0216 · Cited by 6
Priya, P., Srivastava, A., Yadav, N., Mittal, R., Anand, S., Banerjee, J., Tripathi, M., Chandra, P. S., Doddamani, R. S., Sharma, M. C., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.001 · Cited by 6
Плеканчук, В. С., & Ryazanova, M. A. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021010154 · Cited by 6
Zhu, M., Perkins, M. G., Lennertz, R. C., Abdulzahir, A., & Pearce, R. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109215 · Cited by 5
Basak, S., Saikia, N., Kwun, D., Choi, U. B., Ding, F., & Bowen, M. E. (2022) · Biomolecules · doi:10.3390/biom13010004 · Cited by 7
Ionotropic glutamate receptors in GtoPdb v.2023.1
Bettler, B., Collingridge, G. L., Dingledine, R. J., Heinemann, S. F., Hollmann, M., Lerma, J., Lodge, D., Mayer, M. L., Mishina, M., Mulle, C., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f75/2023.1 · Cited by 6
Electrophysiological Investigation of NMDA Current Properties in Brain Slices
Pons-Bennaceur, A., & Lozovaya, N. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7321-7_12 · Cited by 6
Effects of NMDA receptor antagonists on behavioral economic indices of cocaine self-administration
Horchar, M. J., Kappesser, J. L., Broderick, M. R., Wright, M. R., & Yates, J. R. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109348 · Cited by 7
Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs
Neureiter, E. G., Erickson-Oberg, M. Q., Nigam, A., & Johnson, J. W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1561956 · Cited by 5
Boltzmann’s Theorem Revisited: Inaccurate Time-to-Action Clocks in Affective Disorders
Ferber, S. G., Weller, A., & Soreq, H. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240315100326 · Cited by 5
Bechthold, E., Grey, L., Diamant, E., Schmidt, J., Steigerwald, R., Zhao, F., Hansen, K. B., Bunch, L., Clausen, R. P., & Wünsch, B. (2022) · Biological Chemistry · doi:10.1515/hsz-2022-0229 · Cited by 5
Pavlidis, P., Papadopoulou‐Legbelou, K., Tseriotis, V., Karachrysafi, S., Sardeli, C., Gouveris, H. T., Papamitsou, T., Sioga, A., & Kouvelas, D. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-04049-w · Cited by 5
Khodaie, B., Edelmann, E., & Leßmann, V. (2024) · iScience · doi:10.1016/j.isci.2024.109320 · Cited by 5
Cholesterol and Fat Metabolism in Alzheimer’s Disease
Taghibiglou, C., & Khalaj, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00009-x · Cited by 5
Dubovyk, V., & Manahan‐Vaughan, D. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00017 · Cited by 5
Steigerwald, R., Chou, T., Furukawa, H., & Wünsch, B. (2022) · ChemMedChem · doi:10.1002/cmdc.202200484 · Cited by 5
Dutra-Tavares, A. C., Bandeira-Martins, A., Silva, J. D. O., Couto, L. A., Filgueiras, C. C., Ribeiro‐Carvalho, A., Manhães, A. C., & Abreu‐Villaça, Y. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116282 · Cited by 5
Ionotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Bettler, B., Collingridge, G. L., Dingledine, R. J., Heinemann, S. F., Hollmann, M., Lerma, J., Lodge, D., Mayer, M. L., Mishina, M., Mulle, C., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f75/2019.4 · Cited by 5
Forouzanfar, F., Ahmadzadeh, A. M., Pourbagher‐Shahri, A. M., & Gorji, A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177690 · Cited by 4
Zhang, X., Cai, W., Wang, C., & Tian, J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108888 · Cited by 6
Evaluation of 5H‐Thiazolo[3,2‐α]pyrimidin‐5‐ones as Potential GluN2A PET Tracers
He, Y., Whitehead, D. M., Briard, E., Numao, S., Mu, L., Schibli, R., Ametamey, S. M., & Auberson, Y. P. (2020) · ChemMedChem · doi:10.1002/cmdc.202000340 · Cited by 4
Herold, C., Ockermann, P. N., & Amunts, K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.883029 · Cited by 4
Mehr, D. P., Faraji, N., Rezaei, S., & Keshavarz, P. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05818-2 · Cited by 4
Pharmacological Potential of 3-Benzazepines in NMDAR-Linked Pathophysiological Processes
Ritter, N., Disse, P., Wünsch, B., Seebohm, G., & Strutz‐Seebohm, N. (2023) · Biomedicines · doi:10.3390/biomedicines11051367 · Cited by 4
Markus, A., Schreiber, J. A., Goerges, G., Frehland, B., Seebohm, G., Schepmann, D., & Wünsch, B. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200147 · Cited by 4
Bai, H.-H., Zhang, Q., Wu, S., Gao, Y., Li, J., Bai, X., Yang, X., Liu, X.-X., Dang, J.-N., Yang, X. Z., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003516 · Cited by 3
Conformational diversity and fully opening mechanism of native NMDA receptor
Xu, R., Jiang, Q., Xu, H., Zhang, L., Hu, X., Lu, Z., Deng, H., Xiong, H., Zhang, S., Chen, Z., et al. (2026) · Nature · doi:10.1038/s41586-026-10139-w · Cited by 6
Srivastava, J., Yadav, J., & Dubey, N. (2026) · Cognitive Neurodynamics · doi:10.1007/s11571-026-10446-y · Cited by 3
Dedek, A., & Hildebrand, M. E. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3830-9_14 · Cited by 3
Earnhardt-San, A. L., Baker, E. C., Cilkiz, K. Z., Cardoso, R. C., Ghaffari, N., Long, C. R., Riggs, P. K., Randel, R. D., Riley, D. G., & Welsh, T. H. (2025) · Genes · doi:10.3390/genes16020191 · Cited by 3
Joyce, M. K. P., Datta, D., Arellano, J. I., Duque, A., Morozov, Y. M., Morrison, J. H., & Arnsten, A. F. T. (2025) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2025.1553056 · Cited by 3
Kim, H., Jeon, Y., Kim, S., Guo, Y., Kim, D., Jang, G., Brasch, J., Um, J. W., & Ko, J. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102772 · Cited by 3
Absence seizures and sleep–wake abnormalities in a rat model of GRIN2B neurodevelopmental disorder
Hristova, K., Fasol, M., McLaughlin, N., Nawaz, M., Taşkıran, M., Buller‐Peralta, I., Harris, A. P., Sutherland, A., Bassi, A., Ocampo-Garcés, A., et al. (2025) · Epilepsia · doi:10.1111/epi.18606 · Cited by 3
Cannabinoid CB1 Receptor Activation Mitigates N-Methyl- d -aspartate Receptor-Mediated Neurotoxicity
Navarro, G., Raïch, I., Rebassa, J. B., Lillo, J., Pérez-Olives, C., Capó, T., Cubeles-Juberias, E., Saura, C. A., Cordomí, A., Sotelo, E., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00230 · Cited by 3
Structure-Based Virtual Screening to Identify Negative Allosteric Modulators of NMDA
Sherwani, Z. A., Khalil, R., Nur‐e‐Alam, M., Ahmed, S., & Ul‐Haq, Z. (2022) · Medicinal Chemistry · doi:10.2174/1573406418666220304224150 · Cited by 3
Markus, A., Schreiber, J. A., Goerges, G., Frehland, B., Schepmann, D., Daniliuc, C. G., Fröhlich, R., Seebohm, G., & Wünsch, B. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200225 · Cited by 3
Korff, M., Steigerwald, R., Bechthold, E., Schepmann, D., Schreiber, J. A., Meuth, S. G., Seebohm, G., & Wünsch, B. (2022) · Biological Chemistry · doi:10.1515/hsz-2022-0222 · Cited by 3
Esketamine induces apoptosis of nasopharyngeal carcinoma cells through the PERK/CHOP pathway
Cao, Y., Li, H., Gao, Y., Long, J., Zheng, L., Zhang, Q., Li, N., & Chi, X. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116800 · Cited by 3
Schmidt, C. C., Tong, R., & Emptage, N. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0222 · Cited by 4
Identification of C-Terminal Binding Protein 1 as a Novel NMDA Receptor Interactor
Cousins, S. L., & Stephenson, F. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2633-5 · Cited by 4
GRIN2A and GRIN2B and Their Related Phenotypes
Sapuppo, A., Portale, L., Massimino, C. R., Presti, S., Tardino, L. G., Marino, S. D., Polizzi, A., Falsaperla, R., & Praticò, A. D. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727146 · Cited by 3
Metadata
- Authors
- Wyllie, D. J. A., Livesey, M. R., & Hardingham, G. E.
- Affiliations
- University of Edinburgh (GB)
- Corresponding author
- Wyllie, D.J.A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 74
- Pages
- 4-17
- ISSN
- 0028-3908 (ISSN-L)
- PMC
- PMC3778433
- OpenAlex
- W2108909652
- Cited by
- 260
- References
- 161
- Citations by year
- 2026: 6 · 2025: 27 · 2024: 21 · 2023: 16 · 2022: 29 · 2021: 24 · 2020: 20 · 2019: 23 · 2018: 26 · 2017: 18 · 2016: 18 · 2015: 16 · 2014: 10 · 2013: 5
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Neuropharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- The Wellcome Trust
- The Medical Research Council
- The Biotechnology and Biological Science Research Council
- The European Union
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- NMDA receptor, GluN2 subunits, receptor heterogeneity, ionotropic glutamate receptors, receptor subtypes, long-term potentiation, long-term depression, synaptic plasticity, fusion protein, receptor pharmacology, glutamate signalling
- MeSH terms
- Animals, Models, Molecular, Neuronal Plasticity, Receptors, N-Methyl-D-Aspartate, Long-Term Potentiation, Excitatory Amino Acid Antagonists, Protein Subunits, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review